Citigroup
XTNT icon

Citigroup’s Xtant Medical Holdings XTNT Stock Holding History

Citigroup’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,962
Closed -$18.7K – 5808
2024
Q1 		$18.7K Sell
15,962
-46,493
-74% -$51K ﹤0.01% 5048
2023
Q4 		$70.6K Buy
62,455
+56,363
+925% +$66.3K ﹤0.01% 4358
2023
Q3 		$6.7K Buy
+6,092
New +$6.54K ﹤0.01% 4653
2016
Q4 		– Sell
-42
Closed -$1K – 7352
2016
Q3 		$1K Hold
42
– – ﹤0.01% 7000
2016
Q2 		$1K Hold
42
– – ﹤0.01% 7003
2016
Q1 		$1K Hold
42
– – ﹤0.01% 7346
2015
Q4 		$1K Buy
+42
New +$1.48K ﹤0.01% 7426
2015
Q2 		– Sell
-83
Closed -$4K – 7783
2015
Q1 		$4K Buy
+83
New +$3.34K ﹤0.01% 6803
2014
Q2 		– Sell
-91
Closed -$9K – 7338
2014
Q1 		$9K Buy
+91
New +$7.18K ﹤0.01% 6392

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

Citigroup's XTNT Position: Q2 2024 in Review

Citigroup sold out of Xtant Medical Holdings (XTNT) in Q2 2024, closing a stake of 15,962 shares — an estimated $18.7K sold.

Citigroup first reported a position in XTNT in Q1 2014 and held it in 9 quarters. The position peaked at $70.6K in Q4 2023. 27 funds tracked by Wall St. Rank hold XTNT as of Q2 2024.

  • Citigroup reported no remaining Xtant Medical Holdings position as of Q2 2024 after selling out during the quarter.
  • Citigroup sold 15,962 Xtant Medical Holdings shares in Q2 2024, an estimated $18.7K.
  • Citigroup first reported a position in Xtant Medical Holdings in Q1 2014 and held it in 9 quarters.
  • Citigroup's Xtant Medical Holdings position peaked at $70.6K in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2024.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.